“CD8+ As a Predictive Factor for Response to Anthracycline-Based Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer at Dr. Soetomo General Hospital, Surabaya, January 2024-August 2025”. Vascular and Endovascular Review, vol. 8, no. 13s, Nov. 2025, pp. 155-61, https://doi.org/10.64149/.